Healthcare Marketing Agency: The Compliance Questions That Decide Who You Can Hire

The agency sales call has a rhythm you already know: capability deck, case studies, a dashboard with a curve that goes up. Nobody on that call asks what the agency would refuse to run for you. You are about to hire a healthcare marketing agency, which means you are also about to spend real money on campaigns that platform policy limits before anyone writes a word, and the proposal in front of you is silent on which ones those are. Here is what nobody says out loud: healthcare pitches are written for the buyer who will not check. Is the agency on your shortlist prepared to name the tactics it rules out, or will it answer a different question and keep smiling? The gap between those two agencies does not show up in the pitch. It shows up in month four, in a platform review queue and in your review count.
There is a campaign running in your market right now that you cannot run. It works in retail: build an audience around what people care about, retarget everyone who viewed a product page, follow them for two weeks until they buy. Point that machine at a procedure page and it stops. Google's personalized advertising policy treats health-related interests as sensitive, and the restriction holds even when the person visited your own site. So the retargeting layer a retailer takes for granted is switched off for your treatment pages, and the proposal on your desk does not mention it. That silence is the first thing you should notice. The second one is smaller, cheaper to fix, and sitting in your review count.
What Makes Healthcare Marketing Different
Three constraints separate this work from a standard local campaign, and only one of them is about the ad copy. A medical marketing agency worth its retainer names all three before you ask.
The claims layer. The FTC's Health Products Compliance Guidance, revised and expanded from a version that stood for 25 years, requires substantiation for health claims. It also does something most buyers do not realize: a patient testimonial is treated as though the advertiser made the claim directly. "Results not typical" does not cure an atypical outcome. A newer, isolated study cannot carry a claim on its own. A disclosure that contradicts the message of the ad is ineffective, no matter how small the print. The guidance rests on more than 200 enforcement cases, so this is an enforcement history rather than a theory. None of it is legal advice, and an agency is not the party qualified to clear it for you. Your own counsel or compliance team signs off on claims.
The review layer. The FTC's Consumer Reviews and Testimonials Rule, 16 CFR Part 465, took effect on October 21, 2024. Knowing violations carry civil penalties of up to $53,088 per violation as of 2026, and the penalty is counted per violation, so a systematic collection process multiplies it. On December 22, 2025 the FTC sent warning letters to ten unnamed companies under the Rule, which makes enforcement live rather than theoretical. Agencies, PR firms, review brokers and reputation management companies can be liable themselves, not only the practice that hired them. That is why the review question belongs in an agency shortlist rather than in a marketing plan filed somewhere else.
The referral layer. A practice grows on physician referrals, word of mouth and returning patients. A referral behaves nothing like a consumer funnel. You cannot build an audience from it, you cannot retarget it, and you cannot buy it back once a relationship cools. That single difference resets what a paid budget can accomplish here.
The Constraint Questions to Ask Every Agency

Search this market and you will find agency after agency describing itself as compliance-aware, with a HIPAA line and a certification badge. The claim costs nothing to make. What almost nobody in the field offers you is a way to test it. The closest competitor page to a buyer's guide asks "how do you handle compliance-sensitive marketing" and then accepts a single soft sentence as the answer. You can do better with three questions, and you can judge the answers in about ten minutes.
Which tactics do you rule out for regulated clients?
A competent agency answers this with a list, not a policy statement. The most common honest answer names condition-based audience building, lookalike and Customer Match segments for health campaigns, third-party pixels on any page that collects patient information, and review gating.
The detail is what separates the answers. Google's June 2026 clarification for Demand Gen and Discovery classifies health conditions as a sensitive interest category, which restricts Customer Match, your own data segments, audience expansion and lookalikes when the campaign promotes something in that category. Prescription drug services require applying to Google before they can run at all, and certified online pharmacies route through LegitScript plus a separate application, per Google's April 2026 policy changelog. Google also reintroduced limited healthcare professional targeting for eligible advertisers in April 2026, mostly business-to-business, while consumer health targeting stayed restricted. If you sell to medical device manufacturers and to patients, those are two rulebooks. An agency that treats them as one is behind.
A weak answer sounds like this: "we stay within the platform rules and adjust creative as needed." That sentence describes every agency, including the one that will get your account suspended.
Who reviews copy before it ships, and at what stage?
Do not ask whether review happens. Ask which role reviews the copy, at which stage, and what record it leaves. Whether clinical or compliance review sits upstream of the ad being built or downstream as a final polish is the whole question.
There is a reason it has to sit upstream. When a disclosure contradicts the message of the ad, the FTC's guidance treats the disclosure as ineffective, so adding a footnote after the creative is finished does not repair anything. The compliance surface is also wider than the ad itself: Google's practitioner guidance notes that a non-compliant landing page can trigger a policy issue even when the ad copy is fine. Ask an agency to walk you through one piece of copy that was changed before launch and why it changed. An agency with a real workflow can do that from memory. An agency without one will describe its process in the abstract.
How do you handle patient data in your tooling?
Both HHS and the FTC have asserted that web trackers in healthcare settings may violate HIPAA and federal consumer protection law when tracker data can be linked to an individual and becomes protected health information. Four major settled cases total $38.8 million, and dozens of class actions have been filed by patients against healthcare organizations over trackers. The practitioner guidance that follows is blunt: eliminate or opt out of third-party pixel trackers, and lean on aggregated or first-party measurement instead.
One agency page in this field already states the position clearly, saying agencies "use 'clean rooms' for data and avoid using personally identifiable information in tracking pixels" and target on intent rather than patient data. Hold any agency you are considering to that vocabulary, and listen for the answer that reveals the most: a proposal that promises full pixel-based attribution on a patient funnel is telling you exactly which question nobody asked it. This is a question for your own counsel and your privacy officer rather than for the agency.
Why Local Pack and Reviews Beat Paid Reach in Most Practices

Search for a healthcare marketing agency in the United States and three local businesses appear before you reach a single article. That pattern repeats across the practice-level queries your future patients type. The placement carries the demand, and it is not bought.
Review signals determine about 17% of local pack ranking, the third most important factor group after Google Business Profile signals (32%) and on-page signals, according to the Moz Local Ranking Factors 2026 as compiled by Searchlab. A practice with more than 50 reviews is 266% more likely to appear in the local pack than one with fewer than 10, per BrightLocal's 2026 data. Stars in results lift click-through by about 35%. Consumers want recent social proof: 74% look for reviews from the last three months and 32% from the last two weeks, from BrightLocal's 2026 survey of 1,002 US adults. In healthcare specifically, 3 in 4 patients say online reviews are extremely or very important when they choose a provider, from Tebra's fourth annual Patient Perspectives report.
Put those two halves together. The factor that drives your local visibility is also the most tightly policed marketing activity in the vertical. Google prohibits review gating: you may not discourage negative reviews or selectively solicit positive ones, and you have to invite everyone the same way. In April 2026 Google explicitly banned review quotas and directing staff to solicit reviews that name a specific employee. The FTC Rule separately reaches incentives conditioned on a positive review. Google can also strip genuine reviews it is uncertain about, so the penalty for gating can be the loss of real ones.
That leaves one legitimate path to velocity: be operationally excellent at asking every patient, at the right moment, through a permitted channel. Practice guidance in the field points to asking within 24 hours of a visit, leading with a text message, and following up on days three and seven. It is a workflow rather than a campaign, and it is the thing a practice can actually control. The organic side of this overlaps closely with what you would expect from SEO services for small business.
The paid layer still has a job, mostly around high-intent procedure queries where someone is already searching. It cannot build you an audience you own, because retargeting and lookalikes are restricted. A team that plans your paid budget without naming that restriction is planning campaigns you will not be allowed to run, which is the first thing worth checking in any PPC management services proposal you read.
What a Healthcare Engagement Should Cost
Start with the honest framing: the most-cited band for healthcare marketing services comes from agency marketing material on both sides, not from an independent survey.
The commonly published band. A single independent practice, whether medical, dental or aesthetic, spends $2,500 to $10,000 per month, with most engagements landing between $3,000 and $6,000. That band comes from EtherealMinds' 2026 healthcare cost breakdown, updated July 28, 2026, and matches the band used in the Healthcare Success 2026 pricing guide. Multi-location groups start around $10,000 per month. Medical device and health technology companies sit higher, at $8,000 to $20,000 per month, per Buzzbox Media's 2026 analysis. For context, GTM 8020 puts the market-wide median retainer at $3,000 to $5,000.
The arithmetic that beats the dollar figure. Most medical practices allocate 1 to 5% of annual revenue to marketing, rising to 10 to 14% during aggressive growth phases, according to Tebra survey data reported by Improvado and Patient10x in 2026. Between 40 and 60% of a practice marketing budget typically goes to paid advertising, per Patient10x, and 38% of small healthcare practices have no dedicated marketing budget at all, per MGMA data compiled by Searchlab. Run your own numbers: a practice on $2 million in revenue at 3% has about $60,000 a year, which is $5,000 a month, which sits in the middle of the published band. Two things follow. The percentage is a better starting point than any quoted retainer, and ad spend is a separate line paid directly to the platforms.
Why hourly pricing misleads you here. A $2,000 retainer at $100 an hour buys roughly 20 hours of work, per Click Geek's 2026 breakdown. Twenty hours will not cover a review workflow, claim review on every asset, and two managed channels. An hourly quote for a healthcare engagement usually means a scope that excludes the part this article is about.
Where the money goes at scale. Healthcare Success, whose 2026 guide prices by buyer shape rather than by scope, puts a multi-location or regional platform at $400,000 to $700,000 a year fully in-house, or $250,000 to $600,000 in a hybrid model with a lean internal team. One thing that framing leaves out: ask what part of that number buys the constraint work, because that is what keeps the rest of the spend from being wasted.
What to Measure When You Cannot Track Conversions Cleanly
You will not get the attribution you get in e-commerce, and an agency that promises it is either breaking a platform rule or bluffing. The measurement list changes accordingly.
- Calls, tracked with a setup that does not ship patient identifiers to ad platforms.
- Form submissions and booked appointments, ideally reconciled against your practice management system rather than against the ad platform's own count.
- Procedure-page engagement, since someone reading about a specific treatment is closer to booking than someone reading a general services page.
- Branded search growth, which is the cleanest signal that awareness work is landing.
- Review count, recency and reply speed, which will move your local visibility faster than most paid levers.
- Local pack position over time, tracked per location rather than as one average.
A monthly readout that shows impressions rising while nothing in the appointment book changes is a report about the agency's activity, not your business. Four or five numbers that tie to patients beat a dashboard with forty tiles. If you are rebuilding that measurement layer, marketing KPIs is the right place to start, and before you spend anything at all, an SEO audit services engagement tells you what already exists to work with.
Tooling choices also show up in your bill. I run an agency, so I will declare an interest: the reporting surface is where most agency hours quietly disappear, and I moved my own team onto a workspace that holds search data, paid data and reporting in one place, on Pro at EUR 99 a month, Business at EUR 199 or Scale at EUR 399, with a 7-day trial that takes a card. Measurement architecture should be a line item you can see and question, not a black box you pay for by the hour.
When a Generalist Agency Is the Right Answer
A single-location practice under roughly $2 million in revenue is often better served by a good generalist than by a healthcare specialist, and the reason is arithmetic rather than principle. A specialist retainer carries regulated-vertical overhead, and if your traffic problem is a thin local presence and eleven reviews, that overhead buys you nothing yet.
Either way, the generalist still has to answer the three questions above properly. A generalist who says "we have never worked with a clinic, so here is what I would check with your compliance lead before we touch claims, and here is what I would not run" is a stronger hire than a specialist who waves a badge and changes the subject. Depth in a regulated vertical is not the same as knowing one. The B2B SEO agency comparison is useful here if you sell to other businesses rather than to patients, and a startup marketing agency is worth considering if you are pre-revenue and the constraint work has not become the bottleneck yet.
I have a stake in this answer, so weigh it accordingly. I still think a practice paying specialist rates for a generalist problem is the most common overspend I see in this vertical.
Conclusion
The proposal on your desk will not tell you which of its own tactics the rules rule out. That is not because agencies are hiding something, mostly, but because doing the constraint work is harder than claiming it, and because no buyer has been asking. You now have three questions, a cost band with its sources attached, and a measurement list that survives contact with a restricted pixel layer. The next healthcare marketing agency that tells you it is compliance-aware can tell you what it refuses to run, who signs off before your copy ships, and where patient data is not allowed to go. If it cannot answer all three, you have your answer about the fourth.
FAQ
How much does a healthcare marketing agency cost?
For a single practice, the commonly published band is $2,500 to $10,000 per month, with most engagements landing between $3,000 and $6,000, per EtherealMinds (updated July 2026) and the Healthcare Success 2026 guide. Multi-location groups generally start near $10,000 per month. Ad spend sits outside the retainer and is paid directly to the platforms.
Can a general agency handle healthcare marketing?
Often, yes, particularly for a single-location practice under about $2 million in revenue. A general agency can run local search, reviews and one paid channel well. What makes it safe is not specialization, it is process: a named reviewer for claims, a written list of tactics it will not run for a regulated client, and a clear position on patient data in its tooling.
What is different about medical SEO?
The technical work looks like any local SEO. The difference is in what you can publish and what you can target. Health claims need substantiation, testimonials carry the same duty as the practice's own words, review collection cannot be gated or incentivized, and the paid layer cannot be built from health-condition audiences or lookalikes. That narrows the growth you can buy and shifts the weight onto local visibility, review velocity and content that answers patient questions.


